Hypertension after renal transplantation

C. Ponticelli, G. Montagnino, A. Aroldi, C. Angelini, M. Braga, A. Tarantino

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

In 212 cyclosporine-treated renal transplant recipients with stable graft function at 1 year and with potential follow-up of 5 years the prevalence of arterial hypertension was 81.6% at 1 year and 81.2% at 5 years. The logistic regression analysis showed that the presence of hypertension before transplantation (P = 0.0001; odds ratio 3.5), a plasma creatinine level higher than 2 mg/dL at 1 year (P = 0.0001; odds ratio 3.8), and a maintenance therapy with corticosteroids (P = 0.008; odds ratio 3.3) were positively associated with hypertension at 1 year after transplantation. The mean number of graft failures between 1 and 5 years was significantly higher and the mean reciprocal of plasma creatinine was significantly worse at 1 and 5 years in patients with noncontrolled hypertension than in normotensive patients or in patients with hypertension well controlled by drugs. We also investigated the potential protective role of nifedipine. The episodes of acute tubular necrosis (four versus three), of acute rejections (28 versus 29), the mean arterial pressure at 1 year (105 ± 9 versus 104 ± 9 mm Hg) and 5 years (105 ± 10 versus 108 ± 12 mm Hg), and the mean plasma creatinine level at 1 year (1.4 ± 0.4 versus 1.6 ± 0.4 mg/dL) and 5 years (1.8 ± 1 versus 1.9 ± 1 mg/dL) were similar in 52 patients who were given nifedipine for at least 4 years and 58 hypertensive patients who never took calcium channel blockers. To evaluate whether an early administration of nifedipine might have a protective role on the graft we separated patients who started nifedipine within 3 days (17 patients) from those who were given the drug 4 or more days after transplantation (35 patients). No case of acute tubular necrosis was seen in patients treated early, while four cases occurred in the group receiving nifedipine later. The number of rejections (nine versus 19), mean arterial pressure at 1 year (105 ± 8 versus 105 ± 9 mm Hg) and 5 years (105 ± 11 versus 104 ± 9 mm Hg), and the mean plasma creatinine level at 1 year (1.5 ± 0.5 versus 1.5 ± 0.4 mg/dL) and 5 years (1.9 ± 1.5 versus 1.9 ± 0.9 mg/dL) were similar in the two groups.

Original languageEnglish
Pages (from-to)73-78
Number of pages6
JournalAmerican Journal of Kidney Diseases
Volume21
Issue number5 SUPPL. 2
Publication statusPublished - 1993

Fingerprint

Kidney Transplantation
Hypertension
Nifedipine
Creatinine
Transplantation
Odds Ratio
Transplants
Arterial Pressure
Necrosis
Calcium Channel Blockers
Pharmaceutical Preparations
Cyclosporine
Adrenal Cortex Hormones
Logistic Models
Regression Analysis
Kidney

Keywords

  • Antihypertensive treatment
  • Hypertension
  • Immunosuppressive therapy
  • Renal transplantation

ASJC Scopus subject areas

  • Nephrology

Cite this

Ponticelli, C., Montagnino, G., Aroldi, A., Angelini, C., Braga, M., & Tarantino, A. (1993). Hypertension after renal transplantation. American Journal of Kidney Diseases, 21(5 SUPPL. 2), 73-78.

Hypertension after renal transplantation. / Ponticelli, C.; Montagnino, G.; Aroldi, A.; Angelini, C.; Braga, M.; Tarantino, A.

In: American Journal of Kidney Diseases, Vol. 21, No. 5 SUPPL. 2, 1993, p. 73-78.

Research output: Contribution to journalArticle

Ponticelli, C, Montagnino, G, Aroldi, A, Angelini, C, Braga, M & Tarantino, A 1993, 'Hypertension after renal transplantation', American Journal of Kidney Diseases, vol. 21, no. 5 SUPPL. 2, pp. 73-78.
Ponticelli C, Montagnino G, Aroldi A, Angelini C, Braga M, Tarantino A. Hypertension after renal transplantation. American Journal of Kidney Diseases. 1993;21(5 SUPPL. 2):73-78.
Ponticelli, C. ; Montagnino, G. ; Aroldi, A. ; Angelini, C. ; Braga, M. ; Tarantino, A. / Hypertension after renal transplantation. In: American Journal of Kidney Diseases. 1993 ; Vol. 21, No. 5 SUPPL. 2. pp. 73-78.
@article{7715ac2d300d44d197563663a8fdc414,
title = "Hypertension after renal transplantation",
abstract = "In 212 cyclosporine-treated renal transplant recipients with stable graft function at 1 year and with potential follow-up of 5 years the prevalence of arterial hypertension was 81.6{\%} at 1 year and 81.2{\%} at 5 years. The logistic regression analysis showed that the presence of hypertension before transplantation (P = 0.0001; odds ratio 3.5), a plasma creatinine level higher than 2 mg/dL at 1 year (P = 0.0001; odds ratio 3.8), and a maintenance therapy with corticosteroids (P = 0.008; odds ratio 3.3) were positively associated with hypertension at 1 year after transplantation. The mean number of graft failures between 1 and 5 years was significantly higher and the mean reciprocal of plasma creatinine was significantly worse at 1 and 5 years in patients with noncontrolled hypertension than in normotensive patients or in patients with hypertension well controlled by drugs. We also investigated the potential protective role of nifedipine. The episodes of acute tubular necrosis (four versus three), of acute rejections (28 versus 29), the mean arterial pressure at 1 year (105 ± 9 versus 104 ± 9 mm Hg) and 5 years (105 ± 10 versus 108 ± 12 mm Hg), and the mean plasma creatinine level at 1 year (1.4 ± 0.4 versus 1.6 ± 0.4 mg/dL) and 5 years (1.8 ± 1 versus 1.9 ± 1 mg/dL) were similar in 52 patients who were given nifedipine for at least 4 years and 58 hypertensive patients who never took calcium channel blockers. To evaluate whether an early administration of nifedipine might have a protective role on the graft we separated patients who started nifedipine within 3 days (17 patients) from those who were given the drug 4 or more days after transplantation (35 patients). No case of acute tubular necrosis was seen in patients treated early, while four cases occurred in the group receiving nifedipine later. The number of rejections (nine versus 19), mean arterial pressure at 1 year (105 ± 8 versus 105 ± 9 mm Hg) and 5 years (105 ± 11 versus 104 ± 9 mm Hg), and the mean plasma creatinine level at 1 year (1.5 ± 0.5 versus 1.5 ± 0.4 mg/dL) and 5 years (1.9 ± 1.5 versus 1.9 ± 0.9 mg/dL) were similar in the two groups.",
keywords = "Antihypertensive treatment, Hypertension, Immunosuppressive therapy, Renal transplantation",
author = "C. Ponticelli and G. Montagnino and A. Aroldi and C. Angelini and M. Braga and A. Tarantino",
year = "1993",
language = "English",
volume = "21",
pages = "73--78",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "5 SUPPL. 2",

}

TY - JOUR

T1 - Hypertension after renal transplantation

AU - Ponticelli, C.

AU - Montagnino, G.

AU - Aroldi, A.

AU - Angelini, C.

AU - Braga, M.

AU - Tarantino, A.

PY - 1993

Y1 - 1993

N2 - In 212 cyclosporine-treated renal transplant recipients with stable graft function at 1 year and with potential follow-up of 5 years the prevalence of arterial hypertension was 81.6% at 1 year and 81.2% at 5 years. The logistic regression analysis showed that the presence of hypertension before transplantation (P = 0.0001; odds ratio 3.5), a plasma creatinine level higher than 2 mg/dL at 1 year (P = 0.0001; odds ratio 3.8), and a maintenance therapy with corticosteroids (P = 0.008; odds ratio 3.3) were positively associated with hypertension at 1 year after transplantation. The mean number of graft failures between 1 and 5 years was significantly higher and the mean reciprocal of plasma creatinine was significantly worse at 1 and 5 years in patients with noncontrolled hypertension than in normotensive patients or in patients with hypertension well controlled by drugs. We also investigated the potential protective role of nifedipine. The episodes of acute tubular necrosis (four versus three), of acute rejections (28 versus 29), the mean arterial pressure at 1 year (105 ± 9 versus 104 ± 9 mm Hg) and 5 years (105 ± 10 versus 108 ± 12 mm Hg), and the mean plasma creatinine level at 1 year (1.4 ± 0.4 versus 1.6 ± 0.4 mg/dL) and 5 years (1.8 ± 1 versus 1.9 ± 1 mg/dL) were similar in 52 patients who were given nifedipine for at least 4 years and 58 hypertensive patients who never took calcium channel blockers. To evaluate whether an early administration of nifedipine might have a protective role on the graft we separated patients who started nifedipine within 3 days (17 patients) from those who were given the drug 4 or more days after transplantation (35 patients). No case of acute tubular necrosis was seen in patients treated early, while four cases occurred in the group receiving nifedipine later. The number of rejections (nine versus 19), mean arterial pressure at 1 year (105 ± 8 versus 105 ± 9 mm Hg) and 5 years (105 ± 11 versus 104 ± 9 mm Hg), and the mean plasma creatinine level at 1 year (1.5 ± 0.5 versus 1.5 ± 0.4 mg/dL) and 5 years (1.9 ± 1.5 versus 1.9 ± 0.9 mg/dL) were similar in the two groups.

AB - In 212 cyclosporine-treated renal transplant recipients with stable graft function at 1 year and with potential follow-up of 5 years the prevalence of arterial hypertension was 81.6% at 1 year and 81.2% at 5 years. The logistic regression analysis showed that the presence of hypertension before transplantation (P = 0.0001; odds ratio 3.5), a plasma creatinine level higher than 2 mg/dL at 1 year (P = 0.0001; odds ratio 3.8), and a maintenance therapy with corticosteroids (P = 0.008; odds ratio 3.3) were positively associated with hypertension at 1 year after transplantation. The mean number of graft failures between 1 and 5 years was significantly higher and the mean reciprocal of plasma creatinine was significantly worse at 1 and 5 years in patients with noncontrolled hypertension than in normotensive patients or in patients with hypertension well controlled by drugs. We also investigated the potential protective role of nifedipine. The episodes of acute tubular necrosis (four versus three), of acute rejections (28 versus 29), the mean arterial pressure at 1 year (105 ± 9 versus 104 ± 9 mm Hg) and 5 years (105 ± 10 versus 108 ± 12 mm Hg), and the mean plasma creatinine level at 1 year (1.4 ± 0.4 versus 1.6 ± 0.4 mg/dL) and 5 years (1.8 ± 1 versus 1.9 ± 1 mg/dL) were similar in 52 patients who were given nifedipine for at least 4 years and 58 hypertensive patients who never took calcium channel blockers. To evaluate whether an early administration of nifedipine might have a protective role on the graft we separated patients who started nifedipine within 3 days (17 patients) from those who were given the drug 4 or more days after transplantation (35 patients). No case of acute tubular necrosis was seen in patients treated early, while four cases occurred in the group receiving nifedipine later. The number of rejections (nine versus 19), mean arterial pressure at 1 year (105 ± 8 versus 105 ± 9 mm Hg) and 5 years (105 ± 11 versus 104 ± 9 mm Hg), and the mean plasma creatinine level at 1 year (1.5 ± 0.5 versus 1.5 ± 0.4 mg/dL) and 5 years (1.9 ± 1.5 versus 1.9 ± 0.9 mg/dL) were similar in the two groups.

KW - Antihypertensive treatment

KW - Hypertension

KW - Immunosuppressive therapy

KW - Renal transplantation

UR - http://www.scopus.com/inward/record.url?scp=0027195584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027195584&partnerID=8YFLogxK

M3 - Article

VL - 21

SP - 73

EP - 78

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 5 SUPPL. 2

ER -